| NVDA | 11.54% | 180.45 | -0.86% | 1,213,800 | |
| MSFT | 11.21% | 520.17 | -0.44% | 393,095 | |
| GOOGL | 7.73% | 203.90 | +0.47% | 753,550 | |
| AAPL | 7.27% | 231.59 | -0.51% | 654,902 | |
| META | 6.75% | 785.23 | +0.40% | 163,328 | |
| AVGO | 5.04% | 306.34 | -1.57% | 320,880 | |
| LLY | 2.45% | 701.23 | +2.45% | 61,889 | |
| NFLX | 2.16% | 1,238.95 | +0.68% | 34,810 | |
| ORCL | 1.80% | 248.28 | +1.36% | 133,011 | |
| ABBV | 1.43% | 206.69 | +0.98% | 141,408 |
RBC Funds - RBC Life Science and Technology Fund is an open-ended equity mutual fund launched and managed by RBC Global Asset Management Inc. The fund invests in the public equity markets of the United States. It invests in stocks of companies operating in life science and technology sectors. The fund employs combination of fundamental and quantitative analysis along with a bottom-up stock picking approach focusing on companies with strong management, focused business models, competitive advantage, and leading edge technologies with defendable intellectual property. It benchmarks the performance of its portfolio against the 50% S&P 500 Health Care Index and 50% S&P 500 Information Technology Index. The fund was formerly known as Royal Life Science & Technology Fund. RBC Funds - RBC Life Science and Technology Fund was formed in June 30, 1995 and is domiciled in Canada.